Monitoring for and Managing the Adverse Events Associated With Antifibrotic Agents

Multiple sclerosis (MS) is a chronic disease that involves demyelination of plaque throughout the white and gray matter of the central nervous system. The early stages of MS are usually marked by a relapsing-remitting course of neurological deficits, which progress toward continuous, permanent dysfunction and disability. Of those with a diagnosis of MS, 74% are women.

A multi-stakeholder panel discussion featuring insight on the use of prescription digital therapeutics as tools when managing behavior-driven conditions.

As the American population ages, chronic conditions are becoming an increasing challenge for payers. In addition to conditions such as cardiovascular disease and diabetes, eye disease is also prevalent among aging adults.